Recent great advances in the neuropharmacology of the emetic pathways have led to better therapy and improved insight into pathophysiological processes in patients undergoing chemo- and radiotherapy. This article gives an overview of the area, outlines current controversies and makes recommendations for future clinical studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s005200050154 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!